Computational design and clinical demonstration of a copper nanocluster based universal immunosensor for sensitive diagnostics

Nanoparticle based sensors are good alternatives for non-enzymatic sensing applications due to their high stability, superior photoluminescence, biocompatibility and ease of fabrication, with the only disadvantage being the cost of the synthesis process (owing to the expensive precursors and infrast...

Full description

Saved in:
Bibliographic Details
Published in:Nanoscale advances Vol. 2; no. 1; pp. 34 - 314
Main Authors: Kurdekar, Aditya Dileep, Sai Manohar, Chelli, Chunduri, L. A. Avinash, Haleyurgirisetty, Mohan Kumar, Hewlett, Indira K, Kamisetti, Venkataramaniah
Format: Journal Article
Language:English
Published: England RSC 22-01-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nanoparticle based sensors are good alternatives for non-enzymatic sensing applications due to their high stability, superior photoluminescence, biocompatibility and ease of fabrication, with the only disadvantage being the cost of the synthesis process (owing to the expensive precursors and infrastructure). For the first time, we report the design of an immunosensor employing streptavidin conjugated copper nanocluster, developed at a much lower cost compared to other nanomaterials like noble metal nanoparticles and quantum dots. Using in silico tools, we have tried to establish the dynamics of conjugation of nanocluster to the streptavidin protein, based on EDC-NHS coupling. The computational simulations have successfully explained the crucial role played by the components of the immunosensor leading to an efficient design capable of high sensitivity. In order to demonstrate the functioning of the Copper Nanocluster ImmunoSensor (CuNIS), HIV-1 p24 biomarker test was chosen as the model assay. The immunosensor was able to achieve an analytical limit of detection of 23.8 pg mL −1 for HIV-1 p24 with a linear dynamic range of 27-1000 pg mL −1 . When tested with clinical plasma samples, CuNIS based p24 assay showed 100% specificity towards HIV-1 p24. With the capability of multiplexed detection and a cost of fabrication 100 times lower than that of the conventional metal nanoclusters, CuNIS has the potential to be an essential low-cost diagnostic tool in resource-limited settings. Glutathione capped copper nanoclusters were bioconjugated to streptavidin protein using EDC-NHS coupling to engineer the Copper Nanocluster Immunosensor (CuNIS), which was tested for its efficiency by using HIV-1 p24 as the model analyte.
Bibliography:10.1039/c9na00503j
Electronic supplementary information (ESI) available: Characterization of copper nanoclusters, optimization of the CuNIS concentration, the effects of interfering biomolecules and recovery concentration study. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2516-0230
2516-0230
DOI:10.1039/c9na00503j